Guardant Health Gemelli to Establish A Dedicated In-House Liquid Biopsy Testing Service in Italy
What You Should Know:
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced a partnership with the Agostino Gemelli University Polyclinic Foundation IRCCS (“Policlinico Gemelli”) to establish an in-house liquid biopsy testing…
Continue Reading